Hawkwood Biotech Partners

What Hawkwood Biotech Partners does

Hawkwood Biotech Partners, LLC is a San Francisco-based industrial biotechnology consulting firm founded in 2017 and organized as a Delaware LLC. The firm serves industrial biotech companies — from early-stage startups to multinationals — that need to bridge technical and executive teams, scale biological manufacturing, structure partnerships, navigate regulatory pathways, and access capital. Founded by Managing Partners Richard Kenny and Tony Day, both alumni of Solazyme, the firm combines a ~10-person core operating team (Managing Partners, Engineering Partner, Partners, Associates, Analysts, Designer, Executive Assistant) with a network of 20+ consultants-at-large with direct operating experience at Solazyme, DuPont, GE Plastics, Kelco/Merck, Bolt Threads, Impossible Foods, The Every Company, and Checkerspot.

The firm operates three consulting service lines — Engineering & Manufacturing (toll/contract manufacturing selection, techno-economic modeling, scale-up engineering, product/process development), Capital Investments & Acquisition (financial modeling, market landscaping, technical diligence), and Strategy & Commercialization (inorganic growth, IP, regulatory affairs, market analysis & entry, sales strategy, executive strategy, partnership structuring) — alongside BioAtlas, a proprietary centralized database positioned as a comprehensive view of industrial biotech products, players, and markets. Engagements are bespoke with custom scope and team builds, initiated through a website consultation form and supplemented by referrals and network-driven introductions. The firm also operates a venture-building component, most notably co-founding Redux Bio in 2021 alongside Dr. Lincoln Tubbs to commercialize antiviral RNAi for aquaculture. Revenue is generated through professional services fees; no public pricing or revenue disclosure is available.

Name

Hawkwood Biotech Partners

Legal name

Hawkwood Biotech Partners, LLC

Website

https://hawkwoodbiotech.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Hawkwood Biotech Partners is a San Francisco industrial biotech consulting firm that advises startups, divisions, and multinationals on scale-up engineering, capital investments, and strategy/commercialization, with a proprietary BioAtlas database and a 20+ consultant network.

Ownership category

akta.pro rank

Product category

Biotech Consulting Services

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742), Services-Engineering Services (8711)

akta.pro primary industry

Strategic Partnerships, Alliances & JVs Advisory (BPAHADAI)

akta.pro secondary industry

GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

Keywords

• Industrial biotech consulting
• Biotech commercialization services
• Biomanufacturing scale-up
• Precision fermentation advisory
• Biotech strategic planning

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Consulting Services: Professional consulting engagements tailored to client needs, covering technical advisory, strategy, business development, regulatory affairs, and capital investments. Flexible engagement scope with bespoke team compositions.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Hawkwood Biotech Partners provides industrial biotech consulting services covering engineering and manufacturing (toll/contract manufacturing selection, techno-economic modeling, scale-up engineering), capital investments and acquisition (financial modeling, market landscaping, technical diligence), and strategy and commercialization (IP, regulatory affairs, market entry, partnership structuring, executive strategy). The firm complements these services with BioAtlas, a proprietary centralized database tracking industrial biotech products, players, and markets, used for thought leadership and market intelligence.

Product overview

Hawkwood Biotech Partners operates as an industrial biotech consulting firm with a constellation of 20+ consultants-at-large and an extended council of specialist consultants. Its core product offering is BioAtlas — a proprietary centralized database tracking industrial biotech products, players, and markets. The firm complements BioAtlas with three principal consulting service lines: Engineering & Manufacturing (covering toll/contract manufacturing selection, techno-economic modeling, scale-up engineering, and product & process development), Capital Investments & Acquisition (financial modeling, market landscaping, technical diligence), and Strategy & Commercialization (inorganic growth, IP, regulatory affairs, market entry, partnership structuring). The firm also publishes industry case studies (e.g., Bond Pet Foods and Redux Bio) on its blog as thought leadership content illustrating its consulting capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• BioAtlas: Industrial biotech's most comprehensive view of products, players, and markets - a centralized dataset tracking new biotech products as they come online.

Products and services

• BioAtlas Proprietary centralized database providing what Hawkwood describes as industrial biotech's most comprehensive view of products, players, and markets, used for market intelligence and thought leadership.
• Engineering & Manufacturing Consulting Consulting services for industrial biotech clients covering toll and contract manufacturing selection, techno-economic modeling, scale-up engineering, and product and process development.
• Capital Investments & Acquisition Consulting Consulting services covering financial modeling, market landscaping, technical diligence, and advisory for capital investment and acquisition decisions in the biomanufacturing space.
• Strategy & Commercialization Consulting Advisory services covering inorganic growth or acquisition, intellectual property, regulatory affairs, market analysis and entry, sales strategy, executive strategy development, and partnership structuring.

Quantifiable outcome

• Supported Bond Pet Foods in raising a $2.5M seed round and $17.5M Series A funding
• +2 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core and minor.

• Redux BiocoreStrategic or Co-development Partner · 1 January 2021Co-founded by Hawkwood Biotech and Dr. Lincoln Tubbs in 2021. Hawkwood provides technical and commercial support fractionally, including techno-economic modeling, strain development, regulatory and clinical trial strategy. Hawkwood's Richard Kenny serves as VP of Finance and Tony Day as VP of R&D at Redux Bio. A seed investment round was led by Genoa Ventures.
• Plug & PlayminorGTM or Marketing Partner · 1 January 2020Bond Pet Foods, a Hawkwood client, went through Plug & Play's food tech incubator cohort in 2020 to attract investors and hone commercialization strategy. Hawkwood supported this process as part of its ongoing client engagement.
• Hill's Pet NutritioncoreStrategic or Co-development PartnerHill's Pet Nutrition, a leading brand in the $90 billion North American pet food market, signed on as a partner with Bond Pet Foods. The partnership was developed with Hawkwood's guidance and allows Bond to prototype products with a larger pet audience and perform pilot tests.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Cambridge Consultants: Cambridge Consultants is an engineering and technology consulting firm providing deep technical expertise in biotech, process development, and product commercialization — overlapping with Hawkwood's engineering and manufacturing consulting line.
• Frost & Sullivan: Frost & Sullivan is a global market research and consulting firm with deep industrial biotech, chemicals, and sustainability coverage, offering both syndicated research and bespoke advisory engagements.
• Lux Research: Lux Research is a technology and scientific research advisory firm providing intelligence and consulting across industrial biotech, advanced materials, and energy — the closest analog to Hawkwood's research-plus-advisory model with subscription intelligence products.
• Putnam Associates: Putnam Associates is a strategy consulting firm exclusively focused on life sciences, advising biotech and pharma clients on commercial strategy, market entry, and partnerships — closely aligned to Hawkwood's strategy and commercialization practice.
• Back Bay Life Science Advisors: Back Bay is a boutique life science advisory firm providing strategic and capital advisory to growth-stage biotech companies, with comparable size, deal orientation, and client profile to Hawkwood.
• Outcome Capital: Outcome Capital is a life sciences advisory firm offering strategic consulting and investment banking services to emerging and established biotech, medtech, and diagnostics companies — overlapping with Hawkwood's capital advisory and partnership structuring work.

Broad incumbents

• Charles River Associates: CRA is a global consulting firm with a Life Sciences practice that advises biopharma and biotech clients on strategy, pricing, and commercialization — a broader, established incumbent in adjacent advisory work.
• L.E.K. Consulting: L.E.K. is a global strategy consulting firm with a Life Sciences and Healthcare practice serving biotech, pharma, and industrial biotech clients on growth strategy and partnerships — a larger incumbent competing for the same enterprise engagements.
• McKinsey & Company: McKinsey is a global strategy consultancy with biotech, climate, and operations practices serving enterprise clients in industrial biotech and alternative proteins — the largest incumbent competitor in the consulting space Hawkwood occupies.
• Boston Consulting Group: BCG is a global strategy consultancy with a Climate & Sustainability practice that increasingly serves industrial biotech, alternative protein, and biomanufacturing clients — a broad incumbent competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/hawkwoodbiotech

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hawkwood Biotech Partners